Crescita Therapeutics Inc Total Liabilities
Crescita Therapeutics Inc total liabilities. Based on the latest financial reports, Crescita Therapeutics Inc (CTX) has total liabilities worth CA$4.75 Million CAD (≈ $3.44 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Crescita Therapeutics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Crescita Therapeutics Inc (2014–2025)
Total liabilities of Crescita Therapeutics Inc from 2014 to 2025. This chart illustrates how Crescita Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore CTX strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Crescita Therapeutics Inc Competitors by Total Liabilities
The table below lists competitors of Crescita Therapeutics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SL Private Equity
LSE:SLPE
|
UK | GBX142.36 Million |
|
RomReal Limited
OL:ROM
|
Norway | Nkr675.00K |
|
HUHUTECH International Group Inc. Ordinary Shares
NASDAQ:HUHU
|
USA | $14.95 Million |
|
Perfect Moment Ltd.
NYSE MKT:PMNT
|
USA | $12.74 Million |
|
Neungyule Education Inc
KQ:053290
|
Korea | ₩19.28 Billion |
|
K-Tig Ltd
AU:KTG
|
Australia | AU$4.49 Million |
|
TPC Power Holding Public Company Limited
BK:TPCH
|
Thailand | ฿3.42 Billion |
|
Toyo Ventures Holdings Bhd
KLSE:7173
|
Malaysia | RM214.75 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Crescita Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Crescita Therapeutics Inc balance sheet assets.
Liquidity & Leverage Metrics
Crescita Therapeutics Inc Total Liabilities Ratios Explained
Crescita Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Crescita Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Crescita Therapeutics Inc (2014–2025)
The table below shows the annual total liabilities of Crescita Therapeutics Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CA$4.75 Million ≈ $3.44 Million |
-20.09% |
| 2024-12-31 | CA$5.95 Million ≈ $4.30 Million |
+2.96% |
| 2023-12-31 | CA$5.78 Million ≈ $4.18 Million |
-21.82% |
| 2022-12-31 | CA$7.39 Million ≈ $5.34 Million |
-12.02% |
| 2021-12-31 | CA$8.40 Million ≈ $6.07 Million |
+47.37% |
| 2020-12-31 | CA$5.70 Million ≈ $4.12 Million |
-0.54% |
| 2019-12-31 | CA$5.73 Million ≈ $4.14 Million |
-33.06% |
| 2018-12-31 | CA$8.56 Million ≈ $6.19 Million |
-9.52% |
| 2017-12-31 | CA$9.46 Million ≈ $6.84 Million |
-41.65% |
| 2016-12-31 | CA$16.21 Million ≈ $11.73 Million |
+255.95% |
| 2015-12-31 | CA$4.55 Million ≈ $3.29 Million |
+21.86% |
| 2014-12-31 | CA$3.74 Million ≈ $2.70 Million |
-- |
About Crescita Therapeutics Inc
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary drug delivery platforms, which include Multiplexed Molecular Penetration Enhanc… Read more